medmix Full-Year 2024 Results
Ad hoc announcement pursuant to Art. 53 LR Robust performance in challenging market environment
Ad hoc announcement pursuant to Art. 53 LR Robust performance in challenging market environment
We had an extraordinary week at IDS 2025 in Cologne! medmix proudly demonstrated the essence of Swiss precision and dental innovation alongside over 2,000 exhibitors from more than 60 countries. With over 135,000 visitors from around the globe, the 41st IDS 2025 concluded successfully on March 29, 2025.
At today’s annual general meeting (AGM) of medmix Ltd., shareholders approved all proposals of the Board of Directors. medmix will pay an ordinary dividend of CHF 0.50 per share.
In the dynamic and ever-evolving dental care industry, medmix sets itself apart with over 15 years of expertise in delivering world-class contract filling solutions.
medmix has been recognized as one of only nine Swiss companies to achieve an "A" score in CDP's annual climate change assessment, placing it in a select group of global environmental leaders
medmix publishes a full-year as well as a half-year report. The consolidated financial statements are prepared in accordance with International Financial Reporting Standards (IFRS).
Member of the Board of Directors
Member of the Board of Directors Member of the Audit Committee
Member of the Board of Directors Member of the Nomination and Remuneration Committee
Chief Executive Officer - Effective from June 1st, 2024
Chairman of the Board of Directors Chairman of the Nomination and Remuneration Committee
Annual General Meeting 2024
MIXPAC™ greenLine™ sustainable application solutions
medmix News Subscription
medmix engages in an open dialogue with the financial community to provide comprehensive company information.
medmix is committed to the principles of good corporate governance. They ensure a sound balance of power and support the company in creating sustainable value for its various stakeholders.
medmix is currently followed by the brokerage firms listed in alphabetical order below. This list may not be complete and is subject to change as firms initiate, re-initiate or cease coverage of medmix.
Financial Calendar
Annual General Meeting 2023
Annual General Meeting 2022
Annual General Meeting
Vice-Chairman of the Board of Directors Chairman of the Audit Committee
Susanne Hundsbaek-Pedersen
Archived biographies of former members of the Board of Directors who stepped down from their position within the past five years.
Member of the Board of Directors Member of the Compensation Committee Chairwoman of the Audit Committee